211 related articles for article (PubMed ID: 30516167)
41. [Physiopathology of melasma].
Miot LD; Miot HA; Silva MG; Marques ME
An Bras Dermatol; 2009; 84(6):623-35. PubMed ID: 20191174
[TBL] [Abstract][Full Text] [Related]
42. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment.
Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ
Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596
[TBL] [Abstract][Full Text] [Related]
43. Senescent fibroblasts in melasma pathophysiology.
Kim M; Kim SM; Kwon S; Park TJ; Kang HY
Exp Dermatol; 2019 Jun; 28(6):719-722. PubMed ID: 30575141
[TBL] [Abstract][Full Text] [Related]
44. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.
Hofny ERM; Hussein MRA; Ghazally A; Ahmed AM; Abdel-Motaleb AA
J Cosmet Laser Ther; 2019; 21(7-8):382-389. PubMed ID: 31554441
[No Abstract] [Full Text] [Related]
45. Melasma in men: a clinical, aetiological and histological study.
Sarkar R; Puri P; Jain RK; Singh A; Desai A
J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):768-72. PubMed ID: 20015053
[TBL] [Abstract][Full Text] [Related]
46. Defective barrier function in melasma skin.
Lee DJ; Lee J; Ha J; Park KC; Ortonne JP; Kang HY
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1533-7. PubMed ID: 22077137
[TBL] [Abstract][Full Text] [Related]
47. Origin, clinical presentation, and diagnosis of facial hypermelanoses.
Nicolaidou E; Antoniou C; Katsambas AD
Dermatol Clin; 2007 Jul; 25(3):321-6, viii. PubMed ID: 17662897
[TBL] [Abstract][Full Text] [Related]
48. Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed light treatment.
Negishi K; Kushikata N; Tezuka Y; Takeuchi K; Miyamoto E; Wakamatsu S
Dermatol Surg; 2004 Jun; 30(6):881-6; discussion 886. PubMed ID: 15171766
[TBL] [Abstract][Full Text] [Related]
49. The pathogenesis of melasma and implications for treatment.
Artzi O; Horovitz T; Bar-Ilan E; Shehadeh W; Koren A; Zusmanovitch L; Mehrabi JN; Salameh F; Isman Nelkenbaum G; Zur E; Sprecher E; Mashiah J
J Cosmet Dermatol; 2021 Nov; 20(11):3432-3445. PubMed ID: 34411403
[TBL] [Abstract][Full Text] [Related]
50. Mandibular melasma.
Mandry Pagán R; Sánchez JL
P R Health Sci J; 2000 Sep; 19(3):231-4. PubMed ID: 11076368
[TBL] [Abstract][Full Text] [Related]
51. [Melasma and aspects of pigmentary disorders in Asians].
Kang HY
Ann Dermatol Venereol; 2012 Nov; 139 Suppl 3():S92-5. PubMed ID: 23260524
[TBL] [Abstract][Full Text] [Related]
52. How hormones may modulate human skin pigmentation in melasma: An in vitro perspective.
Cario M
Exp Dermatol; 2019 Jun; 28(6):709-718. PubMed ID: 30883945
[TBL] [Abstract][Full Text] [Related]
53. Skin Barrier Function and Its Relationship With IL-17, IL-33, and Filaggrin in Malar Melasma.
Castanedo-Cázares JP; Cortés-García JD; Pérez-Coronado G; Hernández-Blanco D; Torres-Alvarez B
Am J Dermatopathol; 2023 May; 45(5):300-305. PubMed ID: 36939128
[TBL] [Abstract][Full Text] [Related]
54. Poikiloderma of Civatte: a histopathological and ultrastructural study.
Katoulis AC; Stavrianeas NG; Panayiotides JG; Bozi E; Vamvasakis E; Kalogeromitros D; Georgala S
Dermatology; 2007; 214(2):177-82. PubMed ID: 17341870
[TBL] [Abstract][Full Text] [Related]
55. Inflammatory features of melasma lesions in Asian skin.
Noh TK; Choi SJ; Chung BY; Kang JS; Lee JH; Lee MW; Chang SE
J Dermatol; 2014 Sep; 41(9):788-94. PubMed ID: 25132344
[TBL] [Abstract][Full Text] [Related]
56. Melanogenic Properties and Expression Profiles of Melanogenic Paracrine Molecules in Riehl's Melanosis.
Woo YR; Park HE; Jeong SW; Park HJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121626
[TBL] [Abstract][Full Text] [Related]
57. Adaptability of melanocytes post ultraviolet stimulation in patients with melasma.
Wang YJ; Chang CC; Wu YH; Huang L; Shen JW; Lu ME; Chiang HM; Lin BS
Lasers Surg Med; 2023 Sep; 55(7):680-689. PubMed ID: 37365922
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for facial melasma in women: a case-control study.
Handel AC; Lima PB; Tonolli VM; Miot LD; Miot HA
Br J Dermatol; 2014 Sep; 171(3):588-94. PubMed ID: 24749693
[TBL] [Abstract][Full Text] [Related]
59. Increased expression of nerve growth factor receptor and neural endopeptidase in the lesional skin of melasma.
Bak H; Lee HJ; Chang SE; Choi JH; Kim MN; Kim BJ
Dermatol Surg; 2009 Aug; 35(8):1244-50. PubMed ID: 19438666
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
